sepimostate mesilate has been researched along with inogatran in 1 studies
| Studies (sepimostate mesilate) | Trials (sepimostate mesilate) | Recent Studies (post-2010) (sepimostate mesilate) | Studies (inogatran) | Trials (inogatran) | Recent Studies (post-2010) (inogatran) |
|---|---|---|---|---|---|
| 27 | 4 | 1 | 44 | 12 | 2 |
| Protein | Taxonomy | sepimostate mesilate (IC50) | inogatran (IC50) |
|---|---|---|---|
| Prothrombin | Homo sapiens (human) | 0.6585 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for sepimostate mesilate and inogatran
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |